Back

Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II clinical trial

2022-02-09 infectious diseases Title + abstract only
View on medRxiv
Show abstract

We present the results of a randomized, double-blind, placebo-controlled, multi-center clinical trial of the tolerability, safety, and immunogenicity of the inactivated whole virion concentrated purified coronavirus vaccine CoviVac in adult volunteers aged 18-60. Safety of the vaccine was assessed in 398 volunteers who received two doses of the vaccine (n=298) or placebo (n=100). The studied vaccine has shown good tolerability and safety. No deaths, serious adverse events (AE), or other signifi...

Predicted journal destinations

1
Vaccines
131 training papers
Top 0.2% 17.2%
2
Vaccine
140 training papers
Top 1% 11.5%
3
eClinicalMedicine
55 training papers
#1 7.6%
4
PLOS ONE
1737 training papers
Top 67% 7.6%
5
The Lancet Infectious Diseases
57 training papers
Top 0.1% 5.8%
6
Frontiers in Immunology
140 training papers
Top 3% 4.9%
7
New England Journal of Medicine
49 training papers
Top 0.4% 4.9%
8
Clinical Infectious Diseases
219 training papers
Top 10% 3.7%
9
Clinical Microbiology and Infection
54 training papers
Top 1% 1.9%
10
BMJ Open
553 training papers
Top 50% 1.9%
11
Frontiers in Medicine
99 training papers
Top 8% 1.9%
12
International Journal of Infectious Diseases
115 training papers
Top 8% 1.9%
13
Scientific Reports
701 training papers
Top 87% 1.5%
14
The Journal of Infectious Diseases
137 training papers
Top 9% 1.5%
15
Open Forum Infectious Diseases
124 training papers
Top 9% 1.5%
16
Journal of Medical Virology
95 training papers
Top 9% 1.3%
17
Human Vaccines & Immunotherapeutics
20 training papers
Top 0.2% 1.3%
18
JAMA Network Open
125 training papers
Top 20% 1.1%
19
BMJ
49 training papers
Top 5% 0.9%
20
Nature Communications
483 training papers
Top 55% 0.9%
21
Viruses
79 training papers
Top 11% 0.7%
22
Nature Medicine
88 training papers
Top 19% 0.7%
23
The Lancet Respiratory Medicine
16 training papers
Top 0.6% 0.7%
24
Journal of Infection
64 training papers
Top 11% 0.7%